DR. MARK C BATES, MD
Osteopathic Medicine at Chesterfield Ave, Charleston, WV
License number
West Virginia WV15164
Category
Radiology
Type
Vascular & Interventional Radiology
License number
West Virginia WV15164
Category
Osteopathic Medicine
Type
Interventional Cardiology
Address
Address
2345 Chesterfield Ave SUITE 302, Charleston, WV 25304
Phone
(304) 720-2039
(304) 720-2041 (Fax)
(304) 720-2041 (Fax)
Personal information
See more information about MARK C BATES at radaris.comName
Address
Phone
509 Foster Rd, Huntington, WV 25701
Organization information
See more information about MARK C BATES at bizstanding.comW V U Physicians Of Charlston Surgery - Patrick A Stone MD
3200 Maccorkle Ave SE #4, Charleston, WV 25304
Doing business as:
W V U Physicians Of Charlston Surgery - Shadi Abu-Halimah MD<br>W V U Physicians Of Charlston Surgery - David C Carrington MD<br>W V U Physicians Of Charlston Surgery - Mark C Bates MD<br>W V U Physicians Of Charlston Surgery - Aravinda Nanjundappa MD<br>W V U Physicians Of Charlston Surgery - Mohit Srivastava MD<br>W V U PHYS Of Charlston Surg
Site:
Phone:
(304) 388-8199 (Phone)
Categories:
General Surgeons, Physicians & Surgeons, Cardiology Physicians & Surgeons
Professional information
Apparatus And Methods For Reducing Embolization During Treatment Of Carotid Artery Disease
US Patent:
2011016, Jun 30, 2011
Filed:
Mar 8, 2011
Appl. No.:
13/043402
Inventors:
Michael Hogendijk - Palo Alto CA, US
Juan Carlos Parodi - Buenos Aires, AR
Mark C. Bates - Charleston WV, US
Juan Carlos Parodi - Buenos Aires, AR
Mark C. Bates - Charleston WV, US
International Classification:
A61M 29/00
US Classification:
606194
Abstract:
Methods and apparatus are provided for removing emboli during an angioplasty, stenting or surgical procedure comprising a catheter having an occlusion element, an aspiration lumen, and a blood outlet port in communication with the lumen, a guide wire having a balloon, a venous return sheath with a blood inlet port, and tubing that couples the blood outlet port to the blood inlet port. Apparatus is also provided for occluding the external carotid artery to prevent reversal of flow into the internal carotid artery. The pressure differential between the artery and the vein provides reverse flow through the artery, thereby flushing emboli. A blood filter may optionally be included in-line with the tubing to filter emboli from blood reperfused into the patient.
Systems And Methods For Atraumatic Implantation Of Bio-Active Agents
US Patent:
8377032, Feb 19, 2013
Filed:
Dec 14, 2009
Appl. No.:
12/637701
Inventors:
Mark C. Bates - Charleston WV, US
Assignee:
Nexeon MedSystems, Inc. - Encinitas CA
International Classification:
A61M 25/06, A61M 31/00
US Classification:
604506, 604 57, 604 59, 604 60, 604522, 606 1, 606167
Abstract:
Methods and apparatus are provided for delivering a bioactive agent in a needle track formed in a target tissue mass, following formation of the needle track, by avoiding impingement of the agent against target tissue at high velocity or by using capillary action to draw the bioactive agent out of the needle during needle withdrawal. The apparatus comprises a catheter and a needle disposed within the catheter and configured to be selectively extended into the tissue mass to a predetermined depth, while dispensing the agent simultaneously with retraction of the needle along the needle track. Alternatively, or in addition, the needle may be configured to create a tissue space surrounding a distal or lateral surface of the needle, into which the bioactive agent to be infused.
Methods And Apparatus For Treating Infarcted Regions Of Tissue Following Acute Myocardial Infarction
US Patent:
8062283, Nov 22, 2011
Filed:
Sep 22, 2009
Appl. No.:
12/564844
Inventors:
Mark C. Bates - Charleston WV, US
Assignee:
Nexeon Medsystems, Inc. - Charleston WV
International Classification:
A61M 31/00
US Classification:
604522
Abstract:
Apparatus and methods are provided for treating an infracted region of myocardium following acute myocardial infarction by reducing the rate of blood flow through infracted region, and then injecting a solution containing stem cells, endothelial progenitor cells or mediators of stem cell mobilization, migration and attachment into the effected region so that the stem cells become embedded therein and promote tissue regeneration. In a first embodiment, delivery of the stem cells, endothelial progenitor cells or mediators of stem cell mobilization, migration and attachment is accomplished using a catheter that relies upon antegrade flow through the coronary artery and a flow control catheter placed in the coronary sinus. In an alternative embodiment, the delivery catheter delivers the stem cells in a retrograde manner through the coronary sinus, and the delivery catheter further comprises an occlusion balloon for controlling outflow through the coronary sinus ostium.
Apparatus And Methods For Reducing Embolization During Treatment Of Carotid Artery Disease
US Patent:
2010020, Aug 12, 2010
Filed:
Apr 20, 2010
Appl. No.:
12/763923
Inventors:
Michael Hogendijk - Palo Alto CA, US
Juan Carlos Parodi - Buenos Aires, AR
Mark C. Bates - Charleston WV, US
Juan Carlos Parodi - Buenos Aires, AR
Mark C. Bates - Charleston WV, US
International Classification:
A61B 17/22
US Classification:
606200
Abstract:
Methods and apparatus are provided for removing emboli during an angioplasty, stenting or surgical procedure comprising a catheter having an occlusion element, an aspiration lumen, and a blood outlet port in communication with the lumen, a guide wire having a balloon, a venous return sheath with a blood inlet port, and tubing that couples the blood outlet port to the blood inlet port. Apparatus is also provided for occluding the external carotid artery to prevent reversal of flow into the internal carotid artery. The pressure differential between the artery and the vein provides reverse flow through the artery, thereby flushing emboli. A blood filter may optionally be included in-line with the tubing to filter emboli from blood reperfused into the patient.
Emboli Filtration System Having Integral Strut Arrangement And Methods Of Use
US Patent:
6468291, Oct 22, 2002
Filed:
Jan 29, 2001
Appl. No.:
09/774197
Inventors:
Mark C. Bates - Charleston WV
Michael Hogendijk - Palo Alto CA
Michael Hogendijk - Palo Alto CA
Assignee:
Baff LLC - San Francisco CA
International Classification:
A61M 2900
US Classification:
606200, 606159, 604523, 60416413
Abstract:
An emboli filtration apparatus is provided comprising a guide wire having a filter element captured thereon, so that the guide wire is free to rotate or translate while the filter element remains stationary. The apparatus allows for movement and rotation of the guide wire as devices are advanced over it to treat occlusive disease, substantially without dislodging the filter element.
Apparatus For The Delivery Of Drugs Or Gene Therapy Into A Patient's Vasculature And Methods Of Use
US Patent:
7648495, Jan 19, 2010
Filed:
Apr 8, 2004
Appl. No.:
10/822037
Inventors:
Mark C. Bates - Charleston WV, US
Assignee:
Nexeon MedSystems, Inc. - Charleston WV
International Classification:
A61K 9/22
US Classification:
6048901, 6048911, 604 9301, 604104
Abstract:
Methods and apparatus are provided for delivering drugs or gene therapy within a patient's vessel. In a preferred embodiment, the apparatus comprises a material eluting a bioactive substance held in place within the patient's vessel by an anchor. The anchor and eluting material are sized and/or collapsible from a delivery configuration, in which the anchor and material may be delivered into the patient's vasculature within a delivery sheath, to a deployed configuration, wherein the anchor engages an interior wall of the patient's vessel. The eluting material may elute recombinant genes, drugs, or any other bioactive substance.
Implantable Device For Treating Disease States And Methods Of Using Same
US Patent:
2005006, Mar 24, 2005
Filed:
Jun 9, 2004
Appl. No.:
10/864936
Inventors:
Mark Bates - Charleston WV, US
Assignee:
Global Gene Therapies, Inc. - Charleston WV
International Classification:
A61K009/22
US Classification:
424423000, 604890100
Abstract:
Methods and apparatus are provided for delivering drugs, gene vectors, naturally-occurring or synthetic hormones or proteins or other bioactive agents within a patient's vasculature. In a preferred embodiment, the apparatus comprises a material that elutes or secretes a bioactive agent and is held in place within the patient's vessel by an anchor. The material may comprise a biocompatible, and optionally, absorbable matrix, or a culture medium that sustains and nourishes stem cells, spleen cells or pancreatic islets or other beneficial cells. The anchor and material are sized and/or collapsible from a delivery configuration, in which the anchor and material may be delivered into the patient's vasculature within a delivery sheath, to a deployed configuration, wherein the anchor engages an interior wall of the patient's vessel. The apparatus of the invention may be temporarily or permanently implanted, and may in addition self reconfigure after a predetermined period of residency.
Emboli Filtration System And Methods Of Use
US Patent:
7563272, Jul 21, 2009
Filed:
Jan 18, 2005
Appl. No.:
11/037881
Inventors:
Mark C. Bates - Charleston WV, US
Nicola A. Pisano - Rancho Santa Fe CA, US
Nicola A. Pisano - Rancho Santa Fe CA, US
Assignee:
Boston Scientific Scimed, Inc. - Maple Grove MN
International Classification:
A61F 2/01
US Classification:
606200
Abstract:
An emboli filtration apparatus is provided comprising a guide wire having a filter element captured thereon, so that the guide wire is free to rotate and translate while the filter element remains stationary. The apparatus allows for movement and rotation of the guide wire as devices are advanced over it to treat occlusive disease, substantially without dislodging the filter element. In a preferred embodiment, the guide wire comprises a proximal stop configured to reposition the filter element during a medical procedure without having to remove or insert additional interventional devices.
Infusion Catheter Having An Atraumatic Tip
US Patent:
6855136, Feb 15, 2005
Filed:
Apr 25, 2002
Appl. No.:
10/134237
Inventors:
Gerald Dorros - Scottsdale AZ, US
Michael Hogendijk - Palo Alto CA, US
Mark C. Bates - Charleston WV, US
Michael Hogendijk - Palo Alto CA, US
Mark C. Bates - Charleston WV, US
Assignee:
Gore Enterprise Holdings, Inc. - Newark DE
International Classification:
A61M031/00
US Classification:
604508, 604 609, 604 9601, 604523, 604264, 604151, 604528, 604529, 604131
Abstract:
The present invention is directed to apparatus and methods for treating a vascular occlusion by providing an infusion catheter having an atraumatic tip and at least one delivery port configured to infuse fluid into the occlusion. The fluid that is infused dilutes the occlusion and reduces adhesion of the occlusion to an intima of the vessel wall, thereby causing the occlusion to dislodge. Emboli generated in the process are directed into an emboli removal catheter for removal.
Methods And Apparatus For Treating An Injured Nerve Pathway
US Patent:
7842304, Nov 30, 2010
Filed:
Oct 29, 2004
Appl. No.:
10/977593
Inventors:
Mark C. Bates - Charleston WV, US
Assignee:
Nexeon Medsystems, Inc. - San Diego CA
International Classification:
A61B 17/08, A61F 2/00, A61K 48/00, A61M 31/00
US Classification:
424423, 604 57, 604506, 424 9321, 606152
Abstract:
Methods and apparatus are provided for treating an injured or severed nerve pathway, wherein one or more microporous tubes are implanted into the nerve pathway to bridge the injured or severed region. A bioactive matrix including stem cells and nutrients is disposed within the microporous tube to facilitate growth of the stem cells and reestablishment of the sensory and motor conductive pathways through the injured or severed region. The microporous tube protects the bioactive matrix during development of the stem cells, and also retains the end regions in proper alignment during the nerve pathway regeneration.